The Journal of Nutritional Biochemistry
Volume 18, Issue 9 , Pages 629-634 , September 2007

HUM5007, a novel combination of thermogenic compounds, and 3-acetyl-7-oxo-dehydroepiandrosterone: each increases the resting metabolic rate of overweight adults

  • John L. Zenk

      Affiliations

    • Department of Clinical Affairs, Minnesota Applied Research Center, Edina, MN 55435, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 952 400 0402; fax: +1 952 937 7667.
    • ,
  • Joy L. Frestedt

      Affiliations

    • Department of Clinical Affairs, Minnesota Applied Research Center, Edina, MN 55435, USA
    • ,
  • Michael A. Kuskowski

      Affiliations

    • Department of Psychiatry, Geriatric Research Education and Clinical Center, Veterans Administration Medical Center, Minneapolis, MN 55417, USA

Received 25 September 2006 ,Revised 6 November 2006 ,Accepted 10 November 2006.

References 

  1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727
  2. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–1200
  3. Calle EE, Thum MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097–1105
  4. Markus RA, Mack WJ, Azen SP, Hodis HN. Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intimal-media thickness. Am J Clin Nutr. 1997;65:1000–1004
  5. Nisoli E, Carruba MO. Emerging aspects of pharmacotherapy for obesity and metabolic syndrome. Pharmacol Res. 2004;50:453–469
  6. Colditz GA. Economic costs of obesity. Am J Clin Nutr. 1992;55:503S–507S
  7. Mokdad AH, Marks JS, Stroup DF, Gerberdine JL. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238–1245
  8. Astrup A. Thermogenic drugs as a strategy for treatment of obesity. Endocrine. 2000;13:207–212
  9. Astrup A. Macronutrient balances and obesity: the role of diet and physical activity. Public Health Nutr. 1999;2:341–347
  10. Ravussin E, Swinburn BA. Metabolic predictors of obesity: cross-sectional versus longitudinal data. Int J Obes Relat Metab Disord. 1993;17(Suppl 3):S28–S31
  11. Cunningham JJ. Body composition as a determinant of energy expenditure: a synthetic review and a proposed general prediction equation. Am J Clin Nutr. 1991;54:963–969
  12. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621–628
  13. Bray GA. The MONA LISA hypothesis. Most obesities known are low in sympathetic activity. In:  Oomura Y,  Tarui S,  Inoue S,  Shimazu T editor. Progress in obesity research. London: John Libbey & Co; 1990;p. 61–66
  14. Lardy H, Partridge B, Kneer N, Wei Y. Ergosteroids: induction of thermogenic enzymes in liver of rats treated with steroids derived from dehydroepiandrosterone. Proc Natl Acad Sci U S A. 1995;92:6617–6619
  15. Bobyleva V, Bellei M, Kneer N, Lardy H. The effects of the ergosteroid 7-oxo-dehydroepiandrosterone on mitochondrial membrane potential: possible relationship to thermogenesis. Arch Biochem Biophys. 1997;341:122–128
  16. Miyamoto H, Yeh S, Lardy H, Messing E, Chang C. Delta-5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc Natl Acad Sci U S A. 1998;95:11083–11088
  17. Davidson M, Marwah A, Sawchuk RJ, Maki K, Marwah P, Weeks C, et al. Safety and pharmacokinetic study with escalating doses of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy male volunteers. Clin Invest Med. 2000;23:300–310
  18. Lardy H, Kneer N, Wei Y, Partridge B, Marwah P. Ergosteroids II: biologically active metabolites and synthetic derivatives of dehydroepiandrosterone. Steroids. 1998;63:158–165
  19. Kalman DS, Colker CM, Swain MA, Torina GC, Shi Q. A randomized, double blind, placebo controlled study of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweight adults. Curr Ther Res. 2000;61:35–442
  20. Zenk JL, Helmer TR, Kassen LJ, Kuskowski MA. The effect of 7-Keto Naturalean on weight loss: a randomized, double-blind, placebo-controlled trial. Curr Ther Res. 2002;63:263–272
  21. Landsberg L, Young JB. Sympathoadrenal activity and obesity: physiological rationale for the use of adrenergic thermogenic drugs. Int J Obes Relat Metab Disord. 1993;17:S29–S34
  22. Dulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999;70:1040–1045
  23. Tian WX, Li LC, Wu XD, Chen CC. Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase. Life Sci. 2004;74:2389–2399
  24. Anderson RA. Effects of chromium on body composition and weight loss. Nutr Rev. 1998;56:266–270
  25. Preus HG, Anderson RA. Chromium update: examining recent literature 1997–1998. Curr Opin Clin Nutr Metab Care. 1998;1:509–512
  26. Anderson RA, Polansky MM, Bryden MA. Stability and absorption of chromium and absorption of chromium histidinate complexes by humans. Biol Trace Elem Res. 2004;101:211–218
  27. Hoeger WW, Harris C, Long EM, Hopkins DR. Four-week supplementation with a natural dietary compound produces favorable changes in body composition. Adv Ther. 1998;15:305–314
  28. Bahadori B, Wallner S, Schneider H, Wascher TC, Toplak H. Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic subjects during and after a formula diet. Acta Med Austriaca. 1997;24:185–187
  29. Kaats GR, Blum K, Fisher JA, Adelman JA. Effects of chromium picolinate supplementation on body composition: A randomized, double masked, placebo controlled study. Curr Ther Res. 1996;57:747–756
  30. Kaats GR, Blum K, Pullin D, Keith SC, Wood R. A randomized, double masked, placebo controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res. 1998;59:379–388
  31. Crawford V, Scheckenbach R, Preuss HG. Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. Diabetes Obes Metab. 1999;1:331–337
  32. Offenbacher EG. Promotion of chromium absorption by ascorbic acid. J Trace Elem Electrolytes Health Dis. 1994;11:178–181
  33. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr. 2002;21:146S–151S
  34. Zemel MB, Shi H, Greer B, DiRienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J. 2000;14:1132–1138
  35. Shi H, DiRienzo D, Zemel MB. Effects of dietary calcium on adipocyte lipid metabolism and body weight regulation in energy-restricted aP2-agouti transgenic mice. FASEB J. 2001;15:291–293
  36. Heaney RP, Davies M, Barger-Lux MJ. Calcium and weight: clinical studies. J Am Coll Nutr. 2002;21:152S–155S
  37. Teegarden D. Calcium intake and reduction in weight or fat mass. J Nutr. 2003;133:249S–251S
  38. Davies KM, Heaney RP, Recker RR, Lappe JM, Barger-Lux MJ, Rafferty K, et al. Calcium intake and body weight. J Clin Endocrinol Metab. 2000;85:4635–4638
  39. Lin YC, Lyle RM, McCabe LD, McCabe GP, Weaver CM, Teegarden D. Dairy calcium is related to changes in body composition during a two-year exercise intervention in young women. J Am Coll Nutr. 2000;19:754–760
  40. Zemel MB, Thompson W, Milstead A, Morris K, Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res. 2004;12:582–590
  41. Zemel MB, Richards J, Mathis S, Milstead A, Gebhardt L, Silva E. Dairy augmentation of total and central fat loss in obese subjects. Int J Obes Relat Metab Disord. 2005;29:391–397
  42. Marcus R. Agents affecting calcification and bone turnover — calcium, phosphate, parathyroid hormone, vitamin D, calcitonin, and other compounds. In:  Hardman JG,  Limbird LE,  Molinoff PB,  Ruddon RW editor. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw Hill; 1996;p. 1529–1536
  43. Anonymous . Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. JAMA. 2001;285:785–795
  44. Mortensen L, Charles P. Bioavailability of calcium supplements and the effect of vitamin D: comparisons between milk, calcium citrate, and calcium citrate plus vitamin D. Am J Clin Nutr. 1996;63:354–357
  45. Bronner F. Mechanisms and functional aspects of intestinal calcium absorption. J Exp Zoolog A Comp Exp Biol. 2003;300:47–52
  46. Bouillon R, Van Cromphaut S, Carmeliet G. Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J Cell Biochem. 2003;88:332–339
  47. Hoenderop JG, Nilius B, Bindels RJ. Calcium absorption across the epithelium. Physiol Rev. 2005;85:373–422
  48. Danforth E. Diet and obesity. Am J Clin Nutr. 1985;41:1132–1145
  49. Schutz Y, Jequier E. Energy metabolism and dietary-induced thermogenesis in lean and obese subjects. In:  Lardy H,  Stratman F editor. Hormones, thermogenesis and obesity. New York: Elsevier Science Publishing Co. Inc; 1989;p. 59–64
  50. Bouchard C, Tremblay A, Nadeau A. Genetic effect in resting and exercise metabolic rates. Metab Clin Exp. 1989;38:364–370
  51. Astrup AV, Simonsen L, Bulow J, Christensen NJ. The contribution of skeletal muscle to carbohydrate-induced thermogenesis in man. The role of the sympathoadrenal system. In:  Lardy H,  Stratman F editor. Hormones, Thermogenesis and obesity. New York: Elsevier Science Publishing Co. Inc; 1989;p. 187–196
  52. Ravussin E, Lillioja S, Knowler WC. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Eng J Med. 1988;318:467–472
  53. Ravussin E, Burnand B, Schutz Y, Jequier E. Energy expenditure before and during energy restriction in obese subjects. Am J Clin Nutr. 1985;41:753–759
  54. Leibel RL, Hirsch J. Diminished energy requirements in reduced-obese subjects. Metab Clin Exp. 1984;33:164–170
  55. Shutz Y, Golay A, Felber JP, Jequier E. Decreased glucose-induced thermogenesis after weight loss in obese subjects: a predisposing factor for relapse of obesity?. Am J Clin Nutr. 1984;39:380–387
  56. Lennon D, Nagle F, Stratman F, Shrago E, Dennis S. Diet and exercise training effects on resting metabolic rates. Int J Obes. 1985;9(1):39–47
  57. Astrup A, Gotzsche PC, van de Werken K, Ranneries C, Toubro S, Raben A, et al. Meta-analysis of resting metabolic rate in formerly obese subjects. Am J Clin Nutr. 1999;69(6):1117–1122

☆ This trial was sponsored by Humanetics Corporation, Eden Prairie, MN, USA.

PII: S0955-2863(07)00012-5

doi: 10.1016/j.jnutbio.2006.11.008

The Journal of Nutritional Biochemistry
Volume 18, Issue 9 , Pages 629-634 , September 2007

Article Tools